These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 285460)

  • 1. On the mode of action of antimycotics, especially of clotrimazole (Canesten), on the ultrastructural level of human pathogenic fungi.
    Voigt WH
    Scand J Infect Dis Suppl; 1978; (16):51-8. PubMed ID: 285460
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
    Haller I
    Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of action of mechanisms among antimycotic imidazoles.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1981 Jul; 20(1):71-4. PubMed ID: 6269485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
    Berg D; Regel E; Harenberg HE; Plempel M
    Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis for the activity and selectivity of oral antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Coene MC
    Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of novel N-alkyl tetra- and decahydroisoquinolines: novel antifungals that target ergosterol biosynthesis.
    Krauss J; Müller C; Kießling J; Richter S; Staudacher V; Bracher F
    Arch Pharm (Weinheim); 2014 Apr; 347(4):283-90. PubMed ID: 24464607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attack point of ergosterol biosynthesis. Drugs and pharmacology].
    Bracher F
    Pharm Unserer Zeit; 2003; 32(2):118-23. PubMed ID: 12677964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of sulconazole on fungal membrane].
    Beauvais A
    Ann Dermatol Venereol; 1991; 118 Suppl 1():13-4. PubMed ID: 1829878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antifungal activity of a series of difluorotritylimidazoles.
    Bartrolí J; Algueró M; Boncompte E; Forn J
    Arzneimittelforschung; 1992 Jun; 42(6):832-5. PubMed ID: 1418041
    [No Abstract]   [Full Text] [Related]  

  • 12. Bifonazole, a biochemist's view.
    Berg D; Plempel M
    Dermatologica; 1984; 169 Suppl 1():3-9. PubMed ID: 6396116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro and vivo studies of the effect of Canesten on yeast-like fungi].
    Szarmach H; Małyszko E; Trybuła J; Poniecka H; Stepka L; Wroński A
    Przegl Dermatol; 1978; 65(2):205-8. PubMed ID: 663298
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimycotic properties of clotrimazole.
    Plempel M; Büchel KH; Bartmann K; Regel E
    Postgrad Med J; 1974 Jul; 50 Suppl 1():11-2. PubMed ID: 4467159
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlorination-induced enhancement of biological activities in imidazole antimycotics. A possible explanation to the molecular mechanism for their antimycotic activities.
    Kawai K; Shiojiri H; Watanabe R; Nozawa Y
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):255-65. PubMed ID: 6878866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel high energy intermediate analogues with triazasterol-related structures as inhibitors of ergosterol biosynthesis. Part I: synthesis and antifungal activity of N-alkyl-N'-(phenethyl- and cyclohexenylethyl)guanidines and N2-substituted 2-imidazolinamines.
    Gössnitzer E; Malli R; Schuster S; Favre B; Ryder NS
    Arch Pharm (Weinheim); 2002; 335(11-12):535-46. PubMed ID: 12596218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural aspects of Blastocystis hominis.
    Silard R; Panaitescu D; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):233-42. PubMed ID: 6687040
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Canesten HC. Action and tolerance in inflammation of the skin caused or sustained by fungi and/or bacteria].
    Szarmach H; Weuta H; Stepka L
    Med Welt; 1983 Jun; 34(25-26):738-41. PubMed ID: 6888244
    [No Abstract]   [Full Text] [Related]  

  • 20. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
    Ells R; Kock JL; Van Wyk PW; Botes PJ; Pohl CH
    J Antimicrob Chemother; 2009 Jan; 63(1):124-8. PubMed ID: 18971215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.